- Home
- RLAY vs KRC Comparison
RLAY vs KRC Comparison
Compare RLAY & KRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLAY | KRC |
|---|---|---|
| Founded | 2015 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.4B |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | RLAY | KRC |
|---|---|---|
| Price | $19.76 | $36.88 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 12 |
| Target Price | $19.50 | ★ $37.36 |
| AVG Volume (30 Days) | ★ 2.1M | 1.2M |
| Earning Date | 05-05-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 6.57% |
| EPS Growth | ★ 31.78 | 31.07 |
| EPS | N/A | ★ N/A |
| Revenue | $15,355,000.00 | ★ $1,112,667,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $324.03 | $2.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 53.44 | N/A |
| 52 Week Low | $3.44 | $27.36 |
| 52 Week High | $21.27 | $45.03 |
Technical Indicators
Market Signals| Indicator | RLAY | KRC |
|---|---|---|
| Relative Strength Index (RSI) | 54.17 | 44.71 |
| Support Level | $18.02 | $35.94 |
| Resistance Level | $20.59 | $39.90 |
| Average True Range (ATR) | 0.93 | 0.89 |
| MACD | -0.09 | -0.08 |
| Stochastic Oscillator | 48.31 | 35.97 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
About KRC Kilroy Realty Corporation
Kilroy Realty is a premier owner and landlord of approximately 16.3 million square feet of office space across Los Angeles, San Diego, the San Francisco Bay Area, Austin, Texas, and greater Seattle. The company operates as a real estate investment trust.